DARA BioSciences, Inc.
DARA BioSciences, Inc. (DARA), formerly Point therapeutics, Inc. is a development stage pharmaceutical company that acquires therapeutic molecules and medical technologies from third parties, and advances their clinical development for later sale to pharmaceutical and biotechnology companies. DARA focuses on two drug development programs: KRN5500 for neuropathic pain in cancer patients and DB959 for type 2 diabetes. On February 12, 2008, Point and DARA BioSciences, Inc. completed their merger transaction, in which DP Acquisition Corp. (a wholly owned subsidiary of Point) merged with and into DARA BioSciences, Inc.
Contact Details
Office Address
DARA BioSciences, Inc.
8601 Six Forks Road, Suite 160
Raleigh, NC, USA 27615
Phone: (919) 872-5578
Fax: (919) 861-0239
Executives
Chairman & Chief Exec. Officer
Dr. Richard A. Franco Sr.
Consultant
Mr. John C. Thomas Jr.